Trial intelligence / Profile preview

EXTRADOS: Extended Treatment in HIV-HCV Co-infection

NCT00612755Phase 4Completed

Sponsor
Hospital Clínico Universitario San Cecilio
Start
Oct 2005
Primary completion
Jan 2007
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Hospital Clínico Universitario San Cecilio. Started Oct 2005; status: completed.

02

Drugs

peginterferon alfa-2aribavirin
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00612755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00612755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call